Jan 09, 2017 13:02 pm UTC| Business
PHILADELPHIA and OXFORD, United Kingdom, Jan. 09, 2017 -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced that GlaxoSmithKline plc (NYSE:GSK) (LSE:GSK) has...
Gemphire Announces Positive Results for Gemcabene in Proof-of-Concept NASH Preclinical Study
Jan 09, 2017 13:02 pm UTC| Business
LIVONIA, Mich., Jan. 09, 2017 -- Gemphire Therapeutics Inc. (NASDAQ:GEMP) today announced expanded utility for gemcabene with compelling preclinical data results demonstrating proof of concept efficacy in a...
Gemphire Announces Positive Results for Gemcabene in Proof-of-Concept NASH Preclinical Study
Jan 09, 2017 13:02 pm UTC| Business
LIVONIA, Mich., Jan. 09, 2017 -- Gemphire Therapeutics Inc. (NASDAQ:GEMP) today announced expanded utility for gemcabene with compelling preclinical data results demonstrating proof of concept efficacy in a...
Advaxis Provides 2017 Business Outlook
Jan 09, 2017 13:02 pm UTC| Business
PRINCETON, N.J., Jan. 09, 2017 -- Advaxis, Inc. (NASDAQ:ADXS), a clinical-stage biotechnology company developing cancer immunotherapies, today issued its 2017 business outlook to provide an overview of anticipated...
Advaxis Provides 2017 Business Outlook
Jan 09, 2017 13:02 pm UTC| Business
PRINCETON, N.J., Jan. 09, 2017 -- Advaxis, Inc. (NASDAQ:ADXS), a clinical-stage biotechnology company developing cancer immunotherapies, today issued its 2017 business outlook to provide an overview of anticipated...
Major Shareholder Buying Shares
Jan 09, 2017 13:02 pm UTC| Business
TEL AVIV, Israel, Jan. 09, 2017 -- Cellect Biotechnology Ltd. (Nasdaq:APOP) (TASE:APOP), a developer of stem cells isolation technology announces today that it has received notice, from one of the Company’s major...
Major Shareholder Buying Shares
Jan 09, 2017 13:02 pm UTC| Business
TEL AVIV, Israel, Jan. 09, 2017 -- Cellect Biotechnology Ltd. (Nasdaq:APOP) (TASE:APOP), a developer of stem cells isolation technology announces today that it has received notice, from one of the Company’s major...